French drug major Ipsen held its 5th Colloque Medecine et Recherche in the series on Cancer Science in Jaipur, India on the theme "Molecular Targets of Cancer Therapy."
The meeting united leading experts from both academia and the pharmaceutical industry, who brought their unique perspective to the problems inherent in rational drug design. This included two Nobel Prize winners, Michael Bishop and Harold Varmus, who discovered oncogenes. Together, the scientists focused on the steps required to design drugs that target pathways involving genes such as RAS, PI3K and PTEN, mobilizing the immune system against tumors, and combating resistance to targeted therapies.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze